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Introduction: The therapeutic management of bypass failure has been
little studied.
Objectives: Compare prognosis and the occurrence of cardiovascular
events at 2 years in patients with venous bypass graft failure by differentiating
between three patient groups: medical therapy, percutaneous coronary inter-
vention (PCI) in native vessels (native PCI), and PCI in coronary artery
bypass grafts (PCI-CABG).
Methods: Retrospective observational study in patients with bypass graft
failure diagnosed between February 2009 and September 2013 at Poitiers Univer-
sity Hospital, France. Follow-up data at 1 year and at 2 years regarding major
adverse cardiac events (MACEs), defined as death, acute coronary syndrome
(ACS) or revascularization, were collected during patient visits to the department.
Results: From a series of 320 CABG patients examined using coronary
angiography, all patients with bypass graft failure were included in the study
(200 patients). Mean age was 69 years (+/- 11). Coronary angiography was
performed a mean of 117 months after bypass surgery. Medical therapy alone
was chosen in 88 patients, 75 patients underwent native PCI, and 37 patients
underwent PCI-CABG. Patients in the PCI-CABG group were older (73.6
years; p = 0.027) and had significantly older bypass grafts (22% for a period
of more than 10 years; p = 0.018), and their typical clinical presentation was
one of ACS without ST-segment elevation (41%; p = 0.006). The groups were
comparable in terms of hospital complications, except for vascular complica-
tions, which were more common in the PCI-CABG group (8%; p=0.01). At 1
year, no significant difference in terms of MACEs was found, but there was a
trend towards an increase in ACS without ST-segment elevation (11%;
p=0.06) in the PCI-CABG group, and towards an increase in ACS with ST-
segment elevation (7%; p = 0.06) in the medical therapy group. At 2 years, the
medical therapy group stood out by virtue of a significant increase in MACEs
compared with the other two groups (63%; p = 0.02). The native PCI group
presented both fewer MACEs and fewer vascular complications.
Conclusion: MACEs were common and more severe in the medical
therapy group. When coronary lesions are amenable to PCI, PCI in native ves-
sels should be proposed as first-line treatment. PCI of CABG is performed in
a riskier setting and has poorer prognosis.
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The lipopolysaccharide (LPS) is a major component of the Gram-nega-
tive bacteria affects cells of the vasculature causing hypotension by the
initiation of smooth muscle cell hyporeactivity and endothelial dysfunc-
tion. LPS through the Toll-like receptor 4 activates the NF-κB pathway
initiating the transcription of several inflammatory genes as cytokines or
the inducible nitric oxide synthase (iNOS) and finally the overproduction
of nitric oxide (NO). We and other have demonstrated that the deletion of
non muscular myosin light chain kinase (nmMLCK), a kinase implicated
in the regulation of endothelial permeability, enhances survival after intra-
peritoneal injection of LPS and prevents the LPS-induced hyporeactivity
and inflammatory activation. This study was aimed to better understand
the molecular mechanism of the protection of deletion nmMLCK against
LPS-induced vascular alterations. Aortic rings were harvested from
untreated wild-type or nmMLCK deficient mice after injection of LPS
(100μg/kg) for 20 hours and then vascular reactivity, NO production and
iNOS expression in aorta were assessed. Human aortic endothelial cells
were incubated with LPS (10μg/ml) for 3 hours in absence or presence of
ML-7 (5μM), an nmMLCK inhibitor, and NF-κB activation and interaction
of nmMLCK and NF-κB were analyzed. We provide evidence that
nmMLCK deficiency prevents LPS-induced vascular hyporeactivity but
not endothelial dysfunction in the aorta. Deletion of nmMLCK inhibits
both NF-κB activation and the increase of NO release via induction of
iNOS within the vascular wall. In human aortic endothelial cells, LPS-
induced NF-κB activation occurs via increase of nmMLCK activity sensi-
tive to the MLCK inhibitor, ML-7. In addition, nmMLCK co-immuno-
precipitates with NF-κB and vice versa, suggesting physical interactions
between both proteins. We report that NF-κB as a novel partner of
nmMLCK within endothelial cells.
